跳至主要内容
临床试验/NCT00846001
NCT00846001已完成3 期

Study of Resynchronization and CABG Unified Efficacy in Ischemic Heart Failure Patients

Meshalkin Research Institute of Pathology of Circulation4 个研究点 分布在 3 个国家目标入组 178 人开始时间: 2007年9月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
178
试验地点
4
主要终点
Long-term mortality

研究概览

简要总结

The purpose of the study is to compare survivability and efficacy of the patients with severe ischemic heart failure after coronary artery bypass grafting alone and coronary artery bypass grafting with single-step implantation of CRT system (CABG alone vs CABG + CRT )

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women
  • Age 18-80
  • History of ischemic heart failure and indications for CABG
  • LVEF less than 35% estimated by echocardiography measured within 3 months of study entry
  • NYHA and CCS (angina) II-IV functional class
  • Signs of dyssynchrony (at least one of the following three): QRS > 120 ms or dyssynchrony based on Doppler-methods (Tissue Tracking and TSI methods) or CARE HF criteria: Aortic pre-ejection delay >140ms, Interventricular mechanical delay >40 ms, Delayed activation of postero-lateral LV wall

排除标准

  • Failure to provide informed consent.
  • Previous cardiac surgery
  • Non-cardiac illness with a life expectancy of less than 3 year
  • Non-cardiac illness imposing substantial operative mortality
  • Previous heart, kidney, liver, or lung transplantation
  • Current participation in another clinical trial in which a patient is taking an investigational drug or receiving an investigational medical device
  • Successful coronary revascularization (СABG or PCI) within 12 months of study enrollment
  • Chronic atrial fibrillation

结局指标

主要结局

Long-term mortality

时间窗: 6 years

次要结局

  • Mode of Death(6 years)
  • Adverse cardiac events(6 years)
  • Lead performance(6 years)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验